---
title: "Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm | ALLR Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285727236.md"
description: "Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm | ALLR Stock News"
datetime: "2026-05-08T04:45:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285727236.md)
  - [en](https://longbridge.com/en/news/285727236.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285727236.md)
---

# Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm | ALLR Stock News

Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm | ALLR Stock News

### Related Stocks

- [ALLR.US](https://longbridge.com/en/quote/ALLR.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)

## Related News & Research

- [Allarity Therapeutics Q1 net loss per share narrows](https://longbridge.com/en/news/286612460.md)
- [<![CDATA[Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates]]>](https://longbridge.com/en/news/286787081.md)
- [Guardant Health Says US FDA Approved Liquid Biopsy Test](https://longbridge.com/en/news/287069625.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [Enanta Pharma's RSV Bet And Immunology Ambitions](https://longbridge.com/en/news/286895623.md)